Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 180

1.

Viral latency and potential eradication of HIV-1.

Matreyek KA, Oztop I, Freed EO, Engelman A.

Expert Rev Anti Infect Ther. 2012 Aug;10(8):855-7. doi: 10.1586/eri.12.68.

PMID:
23030323
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.

Pierson T, McArthur J, Siliciano RF.

Annu Rev Immunol. 2000;18:665-708. Review.

PMID:
10837072
[PubMed - indexed for MEDLINE]
3.

HAART-persistent HIV-1 latent reservoirs: their origin, mechanisms of stability and potential strategies for eradication.

Kulkosky J, Bray S.

Curr HIV Res. 2006 Apr;4(2):199-208. Review.

PMID:
16611058
[PubMed - indexed for MEDLINE]
4.

Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation.

Shan L, Deng K, Shroff NS, Durand CM, Rabi SA, Yang HC, Zhang H, Margolick JB, Blankson JN, Siliciano RF.

Immunity. 2012 Mar 23;36(3):491-501. doi: 10.1016/j.immuni.2012.01.014. Epub 2012 Mar 8.

PMID:
22406268
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

From reactivation of latent HIV-1 to elimination of the latent reservoir: the presence of multiple barriers to viral eradication.

Shan L, Siliciano RF.

Bioessays. 2013 Jun;35(6):544-52. doi: 10.1002/bies.201200170. Epub 2013 Apr 24. Review.

PMID:
23613347
[PubMed - indexed for MEDLINE]
6.

A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.

Persaud D, Pierson T, Ruff C, Finzi D, Chadwick KR, Margolick JB, Ruff A, Hutton N, Ray S, Siliciano RF.

J Clin Invest. 2000 Apr;105(7):995-1003.

PMID:
10749578
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Reservoirs, sanctuaries, and residual disease: the hiding spots of HIV-1.

Pomerantz RJ.

HIV Clin Trials. 2003 Mar-Apr;4(2):137-43. Review.

PMID:
12671782
[PubMed - indexed for MEDLINE]
8.

Bryostatin-1 synergizes with histone deacetylase inhibitors to reactivate HIV-1 from latency.

Pérez M, de Vinuesa AG, Sanchez-Duffhues G, Marquez N, Bellido ML, Muñoz-Fernandez MA, Moreno S, Castor TP, Calzado MA, Muñoz E.

Curr HIV Res. 2010 Sep;8(6):418-29.

PMID:
20636281
[PubMed - indexed for MEDLINE]
9.

Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART.

Sedaghat AR, Siliciano RF, Wilke CO.

BMC Infect Dis. 2008 Jan 2;8:2. doi: 10.1186/1471-2334-8-2.

PMID:
18171475
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection.

Shen L, Siliciano RF.

J Allergy Clin Immunol. 2008 Jul;122(1):22-8. doi: 10.1016/j.jaci.2008.05.033. Review.

PMID:
18602567
[PubMed - indexed for MEDLINE]
11.

Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure.

Ruff CT, Ray SC, Kwon P, Zinn R, Pendleton A, Hutton N, Ashworth R, Gange S, Quinn TC, Siliciano RF, Persaud D.

J Virol. 2002 Sep;76(18):9481-92.

PMID:
12186930
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Limits on replenishment of the resting CD4+ T cell reservoir for HIV in patients on HAART.

Sedaghat AR, Siliciano JD, Brennan TP, Wilke CO, Siliciano RF.

PLoS Pathog. 2007 Aug 31;3(8):e122.

PMID:
17784786
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Finding a cure for HIV: will it ever be achievable?

Lewin SR, Evans VA, Elliott JH, Spire B, Chomont N.

J Int AIDS Soc. 2011 Jan 24;14:4. doi: 10.1186/1758-2652-14-4.

PMID:
21255462
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

A reservoir for HIV in patients on combination antiretroviral therapy.

Siliciano RF.

Hopkins HIV Rep. 1998 Jan;10(1):1, 5-6, 11.

PMID:
11365130
[PubMed - indexed for MEDLINE]
15.

Autologous neutralizing antibody to human immunodeficiency virus-1 and replication-competent virus recovered from CD4+ T-cell reservoirs in pediatric HIV-1-infected patients on HAART.

Ching N, Nielsen-Saines KA, Deville JG, Wei LS, Garratty E, Bryson YJ.

AIDS Res Hum Retroviruses. 2010 May;26(5):585-91. doi: 10.1089/aid.2008.0274.

PMID:
20455762
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Reservoirs of human immunodeficiency virus type 1: the main obstacles to viral eradication.

Pomerantz RJ.

Clin Infect Dis. 2002 Jan 1;34(1):91-7. Epub 2001 Nov 21.

PMID:
11731950
[PubMed - indexed for MEDLINE]
Free Article
17.

Can HIV infection be eradicated through use of potent antiviral agents?

Josefsson L, Dahl V, Palmer S.

Curr Opin Infect Dis. 2010 Dec;23(6):628-32. doi: 10.1097/QCO.0b013e32833ff1d0. Review.

PMID:
20847693
[PubMed - indexed for MEDLINE]
18.

Activation of latent HIV-1 expression by protein kinase C agonists. A novel therapeutic approach to eradicate HIV-1 reservoirs.

Sánchez-Duffhues G, Vo MQ, Pérez M, Calzado MA, Moreno S, Appendino G, Muñoz E.

Curr Drug Targets. 2011 Mar 1;12(3):348-56. Review.

PMID:
20955147
[PubMed - indexed for MEDLINE]
19.

Effect of histone deacetylase inhibitors on HIV production in latently infected, resting CD4(+) T cells from infected individuals receiving effective antiretroviral therapy.

Blazkova J, Chun TW, Belay BW, Murray D, Justement JS, Funk EK, Nelson A, Hallahan CW, Moir S, Wender PA, Fauci AS.

J Infect Dis. 2012 Sep 1;206(5):765-9. doi: 10.1093/infdis/jis412. Epub 2012 Jun 25.

PMID:
22732922
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

Chun TW, Stuyver L, Mizell SB, Ehler LA, Mican JA, Baseler M, Lloyd AL, Nowak MA, Fauci AS.

Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13193-7.

PMID:
9371822
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk